Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.91 AUD | -3.62% | -1.00% | -6.81% |
04-29 | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
03-14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.81% | 509M | |
-3.35% | 88.91B | |
+2.76% | 41.25B | |
-14.60% | 31.99B | |
+50.51% | 24.73B | |
-14.91% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-15.16% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- CUV Stock
- News Clinuvel Pharmaceuticals Limited
- Clinuvel Pharmaceuticals Says It Has No Deposits at Silicon Valley Bank